Risankizumab-RZAA is a monoclonal antibody used to treat
moderate to severe plaque psoriasis in adults. Like any medication, it comes with potential side effects that patients should be aware of. While it has shown efficacy in managing
psoriasis, it is important to weigh these benefits against the possible adverse reactions.
Common Side Effects:
One of the more frequently reported side effects is
upper respiratory infections, which can include symptoms like a runny nose,
sore throat, and
cough. Other common side effects include
headaches,
fatigue, and
injection site reactions such as
redness,
swelling, or
pain.
Serious Side Effects:
Though rarer, Risankizumab-RZAA can cause more severe side effects. Serious
allergic reactions might occur, characterized by symptoms such as
difficulty breathing, swelling of the face, lips, tongue, or throat, and severe
skin rashes. Immediate medical attention should be sought if these symptoms arise.
Infections:
Risankizumab-RZAA can increase the risk of infections, including serious ones. Patients may experience signs of infection like
fever, chills,
persistent cough, or
painful urination. It is crucial to notify a healthcare provider if any signs of infection appear, as the medication may need to be discontinued or adjusted.
Gastrointestinal Issues:
Some individuals might suffer from gastrointestinal side effects, such as
nausea or
diarrhea. While these are generally less common, they can impact a patient's quality of life and might require intervention if they become severe.
Other Considerations:
Patients with a history of chronic infections or a compromised immune system should discuss these conditions with their healthcare provider before starting Risankizumab-RZAA. Monitoring and regular check-ups can help manage potential risks effectively.
Before starting Risankizumab-RZAA, a comprehensive medical history and discussion of current medications and conditions with a healthcare provider are essential. This helps ensure that the benefits of using Risankizumab-RZAA outweigh its potential risks.
Consultation with a healthcare provider is crucial for anyone experiencing side effects while on Risankizumab-RZAA. They can provide guidance, adjust dosages, or suggest alternative treatments to better manage psoriasis while minimizing adverse reactions.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


